Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05563181 · ClinicalTrials.gov registry record · NA
Evaluation of a Beverage Media Campaign and Added-sugar Warning Labels
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 2,275
- Enrollment target
NCT05563181: Completed NA study, sponsored by University of California, Davis.
NCT05563181 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 2,275 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (62% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05563181, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,275 participants
- Enrollment target
Study Summary
The primary objective of this study is to examine differences in intentions (measured by hypothetical beverage selection) between the following conditions: (1) Control condition: Viewing beverages with a barcode, (2) viewing beverages that have an icon-plus-text warning label, "WARNING: High in added sugar", (3) viewing a campaign message about warning labels in one's preferred language + viewing beverages with a barcode, and (4) viewing a campaign message about warning labels in one's preferred language + viewing beverages with the warning label above. An additional objective is to compare other message reactions and perceptions and perceptions of SSBs (sugar-sweetened beverages) between the conditions. This study will use an online randomized controlled trial among Latino/a/x adults to assign participants to one of the above conditions.
Primary Outcome
Measured in a hypothetical beverage selection task in which participants are shown supermarket shelves containing a variety of sugar-sweetened and non-sugar-sweetened beverages, labeled according to condition. Participants will be asked to select the one beverage they would want to purchase for themselves, and this outcome will be dichotomized as hypothetical selection of an SSB or not. Adapted from doi: 10.2105/AJPH.2021.306488.
Interventions
- BEHAVIORAL Control bar code label
- BEHAVIORAL Warning label
- BEHAVIORAL Informational campaign poster about added-sugar warning labels
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,275 participants |
| Start Date | 2022-10-07 |
| Est. Completion | 2023-03-10 |
| Phase | NA |
What the finished NCT05563181 record still lists
NCT05563181 is an interventional study that assigns participants to a tested intervention. Its 2,275 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (62% higher).
The record links to 0 conditions, and to 3 interventions - of which Control bar code label is the first listed.
NCT05563181 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05563181 about?
NCT05563181 is a clinical study titled "Evaluation of a Beverage Media Campaign and Added-sugar Warning Labels". The primary objective of this study is to examine differences in intentions (measured by hypothetical beverage selection) between the following conditions: (1) Control condition: Viewing beverages with a barcode, (2) viewing beverages that have an icon-plus-text warning label, "WARNING: High in adde...
What is the current status of trial NCT05563181?
This trial is currently completed. It is a NA study. The enrollment target is 2,275 participants. The study started on 2022-10-07. Estimated completion is 2023-03-10.
What interventions are being tested in trial NCT05563181?
The interventions under investigation include: Control bar code label (BEHAVIORAL), Warning label (BEHAVIORAL), Informational campaign poster about added-sugar warning labels (BEHAVIORAL).
Who is sponsoring clinical trial NCT05563181?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05563181's enrollment target sits among peer trials
2,275 48th of 2000 higher than 1,953 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03968393 · 2,270 participants · Phase 4
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
- NCT05530343 · 2,298 participants · NA
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
- NCT04124120 · 2,300 participants · NA
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
- NCT05237258 · 2,300 participants · NA
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI